| | Publication Year | Title | Author(s) |
| 1 | 2-Mar-2011 | Changes in growth factor levels after thermal ablation in a murine model of colorectal liver metastases. | Fifis, Theodora; Malcontenti-Wilson, Caterina; Amijoyo, Jason; Anggono, Beatrice; Muralidharan, Vijayaragavan ; Nikfarjam, Mehrdad ; Christophi, Christopher |
| 2 | 19-Aug-2013 | Comparison of two syngeneic orthotopic murine models of pancreatic adenocarcinoma. | Nikfarjam, Mehrdad ; Yeo, Dannel; He, Hong ; Baldwin, Graham S; Fifis, Theodora; Costa, Patricia; Tan, Bryan; Yang, Eunice; Wen, Shu wen; Christophi, Christopher |
| 3 | 31-Jan-2014 | Glaucarubinone and gemcitabine synergistically reduce pancreatic cancer growth via down-regulation of P21-activated kinases. | Yeo, Dannel; Huynh, Nhi; Beutler, John A; Christophi, Christopher ; Shulkes, Arthur; Baldwin, Graham S; Nikfarjam, Mehrdad ; He, Hong |
| 4 | 17-May-2010 | In vitro and in vivo evaluation of tumor targeting styrene-maleic acid copolymer-pirarubicin micelles: Survival improvement and inhibition of liver metastases. | Daruwalla, Jurstine; Nikfarjam, Mehrdad ; Greish, Khaled; Malcontenti-Wilson, Caterina; Muralidharan, Vijayaragavan ; Christophi, Christopher ; Maeda, Hiroshi |
| 5 | 24-Jan-2007 | Liver regeneration stimulates tumor metastases. | Harun, Nadia; Nikfarjam, Mehrdad ; Muralidharan, Vijayaragavan ; Christophi, Christopher |
| 6 | 15-Nov-2012 | Spatial morphological and molecular differences within solid tumors may contribute to the failure of vascular disruptive agent treatments. | Nguyen, Linh; Fifis, Theodora; Malcontenti-Wilson, Caterina; Chan, Lie Sam; Costa, Patricia Nunes Luiza; Nikfarjam, Mehrdad ; Muralidharan, Vijayaragavan ; Christophi, Christopher |
| 7 | 7-Jun-2007 | Vascular targeting agent Oxi4503 inhibits tumor growth in a colorectal liver metastases model. | Malcontenti-Wilson, Caterina; Chan, Lisa; Nikfarjam, Mehrdad ; Muralidharan, Vijayaragavan ; Christophi, Christopher |